Leo P. Kelly, Ph.D. - Publications
Affiliations: | 2013 | Pharmacology | Rush University, Chicago, IL, United States |
Area:
Pharmacology, Neuroscience Biology, PathologyYear | Citation | Score | |||
---|---|---|---|---|---|
2021 | Persons AL, Desai Bradaric B, Kelly LP, Kousik SM, Graves SM, Yamamoto BK, Napier TC. Gut and brain profiles that resemble pre-motor and early-stage Parkinson's disease in methamphetamine self-administering rats. Drug and Alcohol Dependence. 225: 108746. PMID 34098381 DOI: 10.1016/j.drugalcdep.2021.108746 | 0.473 | |||
2014 | Kelly LP, Carvey PM, Keshavarzian A, Shannon KM, Shaikh M, Bakay RA, Kordower JH. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 999-1009. PMID 24898698 DOI: 10.1002/Mds.25736 | 0.413 | |||
2014 | Chu Y, Goldman JG, Kelly L, He Y, Waliczek T, Kordower JH. Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease. Neurobiology of Disease. 69: 1-14. PMID 24825319 DOI: 10.1016/J.Nbd.2014.05.003 | 0.41 | |||
Show low-probability matches. |